BIOMAT Database Logo BIOMAT Database Logo

Transition metal based anticancer drugs. 2011

K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Nanoscale Organisation and Dynamics Group, School of Biomedical and Health Sciences, College of Health and Science, University of Western Sydney, Locked Bag 1797, Penrith South DC, 1797 NSW, Australia.

With an ageing baby-boomer population in the Western World, cancer is becoming a significant cause of death. The prevalence of cancer and all associated costs, both in human and financial terms, drives the search for new therapeutic drugs and treatments. Platinum anticancer agents, such as cisplatin have been highly successful but there are several disadvantages associated with their use. What is need are new compounds with different mechanisms of action and resistance profiles. What needs to be recognised is that there are many other metal in the periodic table with therapeutic potential. Here we have highlighted metal complexes with activity and have illustrate the different approaches to the design of anticancer complexes.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D028561 Transition Elements Elements with partially filled d orbitals. They constitute groups 3-12 of the periodic table of elements. Elements, Transition

Related Publications

K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs.
March 2009, Journal of inorganic biochemistry,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Transition Metal-based Anticancer Drugs Targeting Nucleic Acids: A Tandem Mass Spectrometric Investigation.
March 2017, Chimia,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Transition Metal-Based Prodrugs for Anticancer Drug Delivery.
January 2019, Current medicinal chemistry,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Gold complexes as prospective metal-based anticancer drugs.
January 2008, Histology and histopathology,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Supramolecular Delivery Systems for Non-Platinum Metal-Based Anticancer Drugs.
January 2017, Critical reviews in therapeutic drug carrier systems,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Research Progress of Metal Anticancer Drugs.
December 2023, Pharmaceutics,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Novel metal-based anticancer drugs: a new challenge in drug delivery.
August 2012, Current opinion in pharmacology,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs.
January 2008, Metal-based drugs,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Mitochondria as a target of third row transition metal-based anticancer complexes.
February 2023, Current opinion in chemical biology,
K Benjamin Garbutcheon-Singh, and Maxine P Grant, and Benjamin W Harper, and Anwen M Krause-Heuer, and Madhura Manohar, and Nikita Orkey, and Janice R Aldrich-Wright
Apoptosis-based anticancer drugs.
February 2002, Nature reviews. Drug discovery,
Copied contents to your clipboard!